Shanghai Fosun Pharmaceutical recently delayed the launch of its US$600 million initial public offering. Shanghai Fosun Pharmaceutical recently delayed the launch of its US$600 million initial public offering.
Shanghai Fosun Pharmaceutical recently delayed the launch of its US$600 million initial public offering.

IPOs: It's all about timing

Topic |   Shanghai Fosun Pharmaceutical
Shanghai Fosun Pharmaceutical recently delayed the launch of its US$600 million initial public offering. Shanghai Fosun Pharmaceutical recently delayed the launch of its US$600 million initial public offering.
Shanghai Fosun Pharmaceutical recently delayed the launch of its US$600 million initial public offering.
READ FULL ARTICLE